FIGURE

Fig. 3

ID

ZDB-FIG-250710-45

Publication

Sang et al., 2025 - Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

(A) The recovery of BuChE inhibitors (donepezil, rivastigmine and 8e) inhibition after dilution with time monitoring. (B) The cell viability (%) of 8e on HT22 cells, PC12 cells and SH-SY5Y cells. (C) Neuroprotective effects of 8e and donepezil on Glu-induced HT22 cell injury. (D) Neuroprotective effects of 8e and donepezil on Aβ25–35-induced HT22 cell injury. (E) Neuroprotective effects of 8e on Aβ25–35-induced PC12 cell injury. (F) The chemical stability of 8e in artificial gastrointestinal fluid. (G) The metabolic stability of 8e in human/rat liver microsomes. (H) The CYP inhibition effects of 8e. (I) In vivo PET-CT images of [11C]8e in mice brain after intravenous administration and time–activity curve. Values are presented as mean ± SD from three independent experiments. ##P < 0.01 vs. control group; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. model group.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Acta Pharm Sin B